Cardiovascular prevention

Overweight or obese patients:  7 trials  - RIO europe 20mg - Rio-lipid 20 mg - RIO-North America 20 mg - RIO europe 5mg - RIO europe (20 vs 5 mg) - AUDITOR - CRESCENDO

rimonabant vs placebo

No demonstrated result

rimonabant 20mg vs placebo

No demonstrated result

suggested weight loss equal to or greater than 5 percent by 151% (not demonstrated)

suggested weight loss equal to or greater than 10 percent by 245% (not demonstrated)

rimonabant 20mg vs rimonabant 5mg

No demonstrated result

rimonabant 5mg vs placebo

No demonstrated result